Recent News for GBT - Global Blood Therapeutics, Inc.

Date Title
Sep 18 Investing In The 'Softer Side' Of Biotech, Without Getting Emotional
Sep 18 Global Blood Therapeutics: STAT Article Sparks Worry, But Much Of It Is Unwarranted
Sep 17 Are Options Traders Betting on a Big Move in Global Blood (GBT) Stock?
Sep 14 INVESTIGATION ALERT: The Schall Law Firm Announces It is Investigating Claims against Global Blood Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Sep 14 Today's Research Reports on Trending Tickers: Ironwood Pharmaceuticals and Global Blood Therapeutics
Sep 13 EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Global Blood Therapeutics, Inc. – GBT
Sep 13 Bragar Eagel & Squire, P.C. is Investigating Global Blood Therapeutics, Inc. (GBT) on Behalf of Stockholders and Encourages Investors to Contact the Firm
Sep 13 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Global Blood Therapeutics, Inc. - GBT
Sep 13 SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Global Blood Therapeutics, Inc. (GBT)
Sep 13 Premarket Losers as of 9:05 am (9/13/2018)
Sep 13 Global Blood down 5% premarket on bearish Feuerstein report
Sep 12 Bluebird Bio Stock May Have Upside of at Least 60 Percent
Sep 10 Global Blood Therapeutics: Iclacumab To Deliver The Pipeline Synergy With Voxelotor
Sep 7 GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference
Sep 6 Biotechs and biopharmas in the red
Sep 6 GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference
Sep 5 3 Biotech Stocks Ready to Burn Up
Aug 30 Global Blood Therapeutics And Inclacumab: Some Context
Aug 28 Oppenheimer’s 7 Top Stock Picks for September
Aug 27 Money flow stays positive in biotechs, XBI up 6% since last week
Aug 23 Global Blood in-licenses sickle cell candidate from Roche; shares up 2% premarket
Aug 23 Today's Research Reports on Trending Tickers: Immunomedics and Global Blood Therapeutics
Aug 23 GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis
Aug 21 GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy
Aug 16 Today's Research Reports on Trending Tickers: Cronos Group and Global Blood Therapeutics

Back to the Main GBT Page...